US RE47,249 E1Grant
Alarm suspend system
Issue Date:2019-02-19
•24 Claims
•6 Drawing Sheets
Abstract
An alarm suspend system utilizes an alarm trigger responsive to physiological parameters and corresponding limits on those parameters. The parameters are associated with both fast and slow treatment times corresponding to length of time it takes for a person to respond to medical treatment for out-of-limit parameter measurements. Audible and visual alarms respond to the alarm trigger. An alarm silence button is pressed to silence the audible alarm for a predetermined suspend time. The audible alarm is activated after the suspend time has lapsed. Longer suspend times are associated with slow treatment parameters and shorter suspend times are associated with fast treatment parameters.
Metadata
Assignee
- MASIMO CORPORATION
Inventors
- Massi Joe E. Kiani
- Steve L. Cebada
- Gregory A. Olsen
Application Information
Application Number:US 15/583,948
Filing Date:2017-05-01
Priority Date:2008-07-29
Art Unit:3992
Classifications
IPC:
G08B5/22A61B5/00G08B25/00A61B5/1455
Field of Search:
A61B 5/1455A61B 5/6826A61B 5/6838A61B 5/746A61B 256/0276G08B 25/001G08B 5/22
Patent Drawings (6 sheets)
Description
Cross-Reference to Related Applications
[0001] This application is an application for reissue of U.S. Pat. No. 9,153,121, issued on Oct. 6, 2015 and titled “Alarm Suspend System,” which is a continuation of U.S. patent application Ser. No. 14/036,496, filed Sep. 25, 2013 and titled “Alarm Suspend System,” which is a continuation of U.S. patent application Ser. No. 13/476,725, filed May 21, 2012 and titled “Alarm Suspend System,” which is a continuation of U.S. patent application Ser. No. 12/510,982 filed Jul. 28, 2009 and titled “Alarm Suspend System,” which claims priority benefit under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 61/084,615, filed Jul. 29, 2008, titled “Alarm Management System;” more than one reissue application has been filed for the reissue of U.S. Pat. No. 9,153,121, including U.S. patent application Ser. No. 15/583,948 (the present application), U.S. patent application Ser. No. 15/583,922, and U.S. patent application Ser. No. 15/583,935.” All of the above-referenced applications are hereby incorporated by reference herein in their entireties.
Background
[0002] Pulse oximetry for measuring constituents of circulating blood has achieved acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios. A pulse oximeter generally includes a two-wavelength optical sensor applied to a patient, a monitor for processing sensor signals and displaying results and a patient cable electrically interconnecting the sensor and the monitor. The monitor typically provides a numerical readout of physiological parameters such as oxygen saturation (SpO2) and pulse rate (PR). Advanced physiological monitors utilize multiple wavelength sensors and enhanced measurement capabilities to provide readouts of additional parameters, such as carboxyhemoglobin (HbCO), methemoglobin (HbMet) and total hemoglobin (Hbt).
[0003] Pulse oximeters capable of reading through motion induced noise are disclosed in at least U.S. Pat. Nos. 6,770,028, 6,658,276, 6,650,917, 6,157,850, 6,002,952, 5,769,785 and 5,758,644; low noise pulse oximetry sensors are disclosed in at least U.S. Pat. Nos. 6,088,607 and 5,782,757; all of which are assigned to Masimo Corporation, Irvine, Calif. (“Masimo”) and are incorporated by reference herein.
[0004] Physiological monitors and corresponding multiple wavelength optical sensors are described in at least U.S. patent application Ser. No. 11/367,013, filed Mar. 1, 2006 and titled Multiple Wavelength Sensor Emitters and U.S. patent application Ser. No. 11/366,208, filed Mar. 1, 2006 and titled Noninvasive Multi-Parameter Patient Monitor, both assigned to Masimo Laboratories, Irvine, Calif. (Masimo Labs) and both incorporated by reference herein.
[0005] Further, physiological monitoring systems that include low noise optical sensors and pulse oximetry monitors, such as any of LNOP® adhesive or reusable sensors, SofTouch™ sensors, Hi-Fi Trauma™ or Blue™ sensors; and any of Radical®, SatShare™, Rad-9™, Rad-5™, Rad-5v™ or PPO+™ Masimo SET® pulse oximeters, are all available from Masimo. Physiological monitoring systems including multiple wavelength sensors and corresponding noninvasive blood parameter monitors, such as Rainbow™ adhesive and reusable sensors and RAD-57™ and Radical-7™ monitors for measuring SpO2, pulse rate (PR), perfusion index (PI), pleth variability index (PVI), signal quality, HbCO and HbMet among other parameters are also available from Masimo.
Summary of the Invention
[0006] Monitor alarms are triggered by out-of-limit parameters and system failures, the latter including monitor or sensor failures or improper sensor placement, to name a few. Alarms can be visual, audible or both. Alarms can also have different levels of priority, which are reflected in the type of visual and audible alarms. In an embodiment, parameters exceeding limits such as low SpO2, high HbCO, high HbMet and low and high BPM trigger high priority alarms. System failures due to sensor off, no sensor or defective sensor also trigger high priority alarms. Parameters exceeding limits such as high SpO2, low and high PI, low and high PVI, for example, trigger medium priority alarms. Parameters exceeding limits such as low HbCO and low HbMet along with a system low battery indication are examples of low priority alarms.
[0007] An audible alarm may be temporarily suspended by pressing an alarm silence button so as to prevent unnecessary disturbance to the patient and distraction of the caregiver. During alarm suspension, visual alarms remain active. If an alarm condition persists after a predetermined alarm suspend period, the audible alarm resumes. The alarm suspend period is typically long enough to give a caregiver sufficient time to intervene with appropriate patient treatment yet short enough to ensure that patient health is not endangered if intervention is ineffective. For conventional pulse oximetry, an alarm suspend may be, for example, a maximum of 120 seconds.
[0008] Alarm suspension on advanced blood parameter monitors is problematic. With conventional pulse oximetry, treatment for abnormal parameter measurements can be quickly applied and a patient response is typically fast. For example, a treatment for low oxygen saturation is the application of an oxygen mask or an increase in oxygen flow. By contrast, the duration of treatment for parameters measured by advanced monitors is highly dependent on the alarm-triggering parameter. For example, the treatment for high methemoglobin is the injection of methylene blue, and the patient response to such an injection is slow. When patient treatment time exceeds the maximum alarm suspend period, an audible alarm will constantly reactivate. Thus, a single alarm suspend duration for all parameters is inadequate to cope with the many different types of parameters measured by advanced monitors.
[0009] One aspect of an alarm suspend system for silencing the alarms is an alarm trigger responsive to any of various parameters and predetermined limits corresponding to the parameters, where the parameters are partitioned according to treatment time, i.e. the relative length of time it takes for a person to respond to medical treatment for a parameter measurement outside of the predetermined limits. An audible alarm is responsive to the alarm trigger. An alarm silence button is actuated so as to suspend the audible alarm. A timer tracks the duration of the suspended alarm and is initiated by actuation of an alarm silence button. The timer retriggers the audible alarm after the timed duration has lapsed/expired. In an embodiment, a long duration suspend time is associated with slow treatment parameters and a short duration suspend time is associated with fast treatment parameters. Fast treatment parameters may include, for example, parameters relating to normal blood hemoglobin constituents and slow treatment parameters may include parameters relating to abnormal blood hemoglobin constituents.
[0010] In various embodiments, a short duration suspend time is less than or equal to about two minutes and a long duration suspended time is greater than about two minutes. A default duration associated with the fast treatment parameters is about two minutes and a default duration associated with the slow treatment parameters is about fifteen minutes. The alarm suspend system may also have an alarm suspend override responsive to a predetermined unit change in the parameter triggering a suspended alarm. The override results in reactivation of the suspended alarm. A physiological monitor having an alarm suspend system may also have a pop-up window that appears on the monitor display in response to actuation of the silence button, where the pop-up window presents a choice of alarm suspend durations.
[0011] Another aspect of an alarm suspend system is a partition of measured parameters into at least a first group and a second group. An audible alarm is triggered if at least one parameter is outside of predetermined limits. The audible alarm is suspended in response to a silence request. A first duration is associated with the first group and a second duration is associated with the second group. The audible alarm is reactivated after at least one of the first duration and the second duration. The first duration may be set so as to generally correspond to a first range of treatment times for the first group of parameters. Likewise, the second duration may be set so as to generally correspond to a second range of treatment times for the second group of parameters, where the first range of treatment times and the second range of treatment times are non-overlapping.
[0012] In various embodiments, suspended audible alarms are overridden if the triggering parameter has greater than a predetermined unit change before the suspended alarm expires according to either the first duration or the second duration. The first and second groups are defined in relation to normal hemoglobin measurements abnormal hemoglobin measurements, respectively. The first duration is set to be less than or equal to two minutes and the second duration is set to be greater than two minutes, with default durations of about two minutes corresponding to the first group and about fifteen minutes corresponding to the second group. In an embodiment, a pop-up window for a monitor display is constructed and the first duration and the second duration are selected from a range of durations presented within the pop-up window.
[0013] A further aspect of an alarm suspend system deactivates an audible alarm for one of a short duration and a long duration according to the alarm-triggering parameter. A first group of parameters is associated with the short duration and a second group of parameters is associated with the long duration. The first group and the second group are partitioned according to a fast treatment time and a short treatment time associated with the parameters. An override reactivates the audible alarm if the trigger parameter changes more than a predetermine amount during the corresponding duration. In various embodiments, the first group comprises parameters related to the measurement of normal hemoglobin and the second group comprises parameters related to the measurement of abnormal hemoglobin. The long duration is greater than about 120 seconds and the short duration is less than or equal to about 120 seconds. A pop-up window for the display allows selection of the long duration and the short duration in response to the silence button.
Brief Description of the Drawings
[0014] FIG. 1 is a perspective view of a physiological measurement system utilizing an alarm suspend system;
[0015] FIG. 2 is a detailed block diagram of a physiological measurement system utilizing an alarm suspend system;
[0016] FIG. 3 is a flow diagram of an alarm suspend system embodiment;
[0017] FIG. 4 is a state diagram of an alarm suspend system embodiment; and
[0018] FIG. 5 is an illustration of an alarm suspend pop-up window.
Detailed Description
[0019] FIG. 1 illustrates a physiological measurement system 100 that utilizes an alarm suspend system. The physiological measurement system 100 has a noninvasive sensor 105 attached to a tissue site 10, a physiological monitor 101, and an interface cable 109 interconnecting the monitor 101 and the sensor 105. The physiological measurement system 100 may incorporate pulse oximetry in addition to advanced features, such as a multiple wavelength sensor and advanced processes for determining physiological parameters other than or in addition to those of pulse oximetry, such as carboxyhemoglobin, methemoglobin and total hemoglobin, as a few examples.
[0020] The monitor 101 has a front panel 110 providing a display 120, touch keys 130, controls 140, a speaker 150, a sensor port 160 and status indicators 170. The display 120 shows parameter readouts, limits and waveforms among other items. The display 120 also has touch key icons 122 that indicate touch key 130 functions. The speaker 150 provides an audible alarm in response to physiological measurements that violate preset conditions, such as an out-of-limit parameter, as well as system failures, such as a low battery condition. The controls 140 include an alarm silence button 144 that is pressed to temporarily suspend out-of-limit parameter alarms and system alarms, such as low battery. The display 120 provides visual alarms, which include a bell-shaped alarm status indicator 124 that illuminates during an alarm condition and parameter readouts 210 and limits 220 that flash when parameters are out-of-limit. Status indicators 170 also provide visual alarms. When there are multiple alarm conditions, the parameter displays 202 indicate parameters with the highest alarm priority. Touch keys 130 and corresponding icons 122 include an alarm menu access button for setting alarm conditions, such as high or low alarm limits for SpO2, HbCO, HbMet, PR and PI. The alarm silence button 144 is pressed to temporarily suspend audible alarms. Advantageously, an alarm suspend system provides a parameter-dependent variation in the alarm suspend duration, as described below, utilizing a common silence button or other suspend initiator.
[0021] FIG. 2 illustrates a physiological measurement system 200 including a physiological monitor 201, a sensor 205 and an interface cable 209. The sensor 205 is attached to a tissue site, such as a finger 10, and includes a plurality of emitters 206 irradiating the tissue site 10 with multiple wavelengths of light. The sensor 205 also includes one or more detectors 208 capable of detecting the light after attenuation by the tissue site 10. The sensor 205 transmits optical radiation at wavelengths other than or including the red and infrared wavelengths utilized in pulse oximeters. The monitor 201 inputs a corresponding sensor signal 211 and determines the relative concentrations of blood constituents other than or in addition to the “normal” blood hemoglobin constituents HbO2 and Hb, including “abnormal” blood hemoglobin constituents HbCO, HbMet and blood related parameters such as fractional oxygen saturation, total hemoglobin and blood glucose to name a few.
[0022] As shown in FIG. 2 , the monitor 201 has a front-end signal conditioner 210, an A/D converter 220, emitter drivers 230, D/A converters 240 and a digital signal processor (“DSP”) 250. In general, the emitter drivers 230 convert digital control signals, via the D/A converters 240, into analog drive signals capable of driving the sensor emitters 206. The front-end signal conditioner 210 converts, via the A/D converter 220, composite analog intensity signal(s) from light sensitive detector(s) 208 into digital data input to the DSP 250. The emitter drivers 230 and front-end signal conditioner 210 communicate with the sensor 205 via the interface cable 209.
[0023] Also shown in FIG. 2 , the monitor 201 has an instrument manager 260 and a user interface 280. The user interface 280 includes one or more displays 282, alarms 284 and user input/output (I/O) 286. The instrument manager 260 communicates with the DSP 250 to receive parameter data and to present that data on the display 282. The instrument manager 260 may also store and display historical or trending data related to one or more of the measured parameters or combinations of the measured parameters. The instrument manager 260 also controls audible and visual alarms and indicators 284. The instrument manager 260 responds to user-actuated keys and communicates with external devices via various I/O ports 286. Further, the instrument manager 260 executes alarm suspend firmware 270 so as to respond to an alarm silence button press 288, as described in detail with respect to FIGS. 3-4 .
[0024] FIG. 3 generally illustrates an alarm suspend system 300. Alarm triggers include system failures 338 and out-of-limit parameters 318. Triggered alarms 340 may be audible, visual or both, and may vary according to priority 342. Audible alarms may be generated by a monitor front-panel-mounted speaker 150 (FIG. 1 ) and may vary in loudness, pitch and sound pattern. Visual alarms may include parameter labels, parameter numerics, symbols and status lights, which can flash and vary in color.
[0025] As shown in FIG. 3 , measured parameters 312 are compared 310 to default or user-specified limits 314. An out-of-limit condition 318 triggers an alarm 340. An alarm suspend 328 is user-initiated by a silence request 322. This may be a press of a silence button 144 (FIG. 1 ) on a monitor front panel 110 (FIG. 1 ). In an embodiment, the alarm suspend 328 silences audible alarms and modifies the display of visual alarms. The alarm suspend 328 is based on a timer 320, which ends the alarm suspend 328 after a predetermined duration 324. The duration 324 may be a function of the out-of-limit parameter 312. In an advantageous embodiment, the duration 324 relates to, or is a function of, the treatment time for the alarm-triggering parameter so as to avoid nuisance alarms while maintaining alarm integrity.
[0026] FIG. 4 illustrates an alarm suspend embodiment 400 that operates independently for each measured parameter that can trigger an alarm. An alarm is initially off 410. The alarm remains off as long as the parameter is within its set limits 412. If a parameter is measured outside of its set limits 414, an alarm is triggered 420. The alarm may audible, visual or both audible and visual. A user can request to silence the alarm by pressing an alarm silence button 144 (FIG. 1 ), for example. The silence request 422 suspends the alarm 430 which turns off audible alarms but, in an embodiment, does not deactivate visual alarms. The audible alarm remains suspended 430 for a predetermined duration 432. When the suspend duration has passed, the alarm suspend expires 434 and audible alarms are once again activated 420. The alarm remains on 428 until the triggering parameter is within limits 424 or a user once again requests silence 422. The alarm suspend 430 deactivates if the measured parameter becomes within limits 438, such as when the patient condition improves, or if no physiological data is detected 439, such as no sensor, sensor off, no cable or malfunctioning sensor situations, to name a few. Also, if the measured parameter changes during the alarm suspend 430 by a sufficient out-of-limit amount, an override 436 reactivates the audible alarms 420.
[0027] In an alarm suspend system embodiment, parameters are classified according to the typical time it takes for medical treatment to transition an out-of-limit measurement to a within-limit measurement. Suspend durations 324 (FIG. 3 ) are set accordingly. For example, in a two-tier embodiment, relatively slow treatment parameters, such as HbMet, HbCO, Hbt and PVI, are assigned relatively long suspend durations. Similarly, relatively fast treatment parameters, such as SpO2 and PR, are assigned relatively short suspend durations. In an embodiment, the alarm suspend duration is adjustable for each individual parameter, including 2, 5, 10, 15, 20, 25 and 30 minutes for slow treatment parameters, with a default of 15 minutes; and 30, 60, 90 and 120 seconds for fast treatment parameters, with a default of 120 seconds. These alarm features are only active when alarm limits have been set. Other alarm features apply to both slow treatment and fast treatment parameters. For example, an alarm delay of 0, 5, 10 or 15 seconds applies to all enabled parameters.
[0028] In an embodiment, an override 436 occurs if slow treatment parameters such as HbCO, HbMet or PVI increase or Hbt decreases by a certain unit change during the alarm suspend duration. The unit change is adjustable for each parameter, such as from 1-15 in increments of 1. TABLE 1 shows a default embodiment of override unit changes for these parameters.
[0029]
| TABLE 1 | |||
|---|---|---|---|
| Override Unit Changes for Selected Parameters | |||
| Parameter | Unit Change | Direction | |
| HbCO | 5 | Increase | |
| HbMet | 2 | Increase | |
| Hbt | 2 | Decrease | |
| PVI | OFF | Increase | |
[0030] FIG. 5 illustrates an alarm suspend window 500 that provides a “pop-up” display so that a monitor user may manually enter an alarm suspend duration. The alarm suspend window 500 appears as a portion of a monitor display 501, such as the front panel display 120 (FIG. 1 ) described above. The pop-up window 500 responds to a suspend request, such as a silence button 144 (FIG. 1 ) press. The alarm suspend window 500 has a window identifier 502 and one or more parameter subsections 510, 520. Each parameter subsection 510, 520 has a parameter identifier 512, 522 and corresponding suspend duration options 514, 524. In an embodiment, specific suspend times are selected via monitor touch keys 130 (FIG. 1 ) as guided by corresponding touch key icons 560. Selected suspend times are highlighted or otherwise identified and entered, also via a touch key 130 (FIG. 1 ). In an alternative embodiment, the monitor display is a touch screen and alarm suspend times are directly entered by a finger press on a specific duration “virtual button” 514, 524. Once one or more suspend durations are entered, the pop-up window 500 disappears from the display 501. The alarm suspend window 500 advantageously allows a user to quickly choose an appropriate alarm suspend duration for the situation at hand, rather than relying on a predetermined or default duration.
[0031] An alarm suspend system is described above with respect to alarms triggered by measured parameters and limits associated with those measured parameters. Limits may correspond to levels of a measured parameter, such as a percentage oxygen saturation to name but one example. Limits may also correspond to trends of a measured parameter, such as a rate-of-change of oxygen saturation, for example. Limits may also correspond to patterns in a measured parameter or a comparison of one measured parameter with another measured parameter, as further examples.
[0032] An alarm suspend system is described above with respect to a two-tier grouping of parameters, such as slow treatment and fast treatment parameters and alarm suspend durations associated with those groups. Groupings of parameters with respect to alarm suspend durations may be multi-tier, such as slow, medium and fast treatment parameters, to name but one example.
[0033] An alarm suspend system has been disclosed in detail in connection with various embodiments. These embodiments are disclosed by way of examples only and are not to limit the scope of the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications.
Claims
Post-issuance certificates present
The text shown below may not reflect later post-issuance changes.
What is claimed is:
1. A physiological measurement system comprising:
a noninvasive physiological sensor including: a plurality of light emitting diodes configured to transmit wavelengths of light onto a tissue site of a patient; and at least one detector configured to measure an indication of the wavelengths of light after attenuation by tissue of the patient and be positioned on a patient and output a signal responsive of the attenuated light to a physiological condition of the patient; and
one or more processors in communication with the noninvasive physiological sensor, the one or more processors configured to electronically:
determine a measurement of a physiological parameter based at least in part upon the signal;
determine whether an alarm condition exists by determining whether an activation threshold has been satisfied by the measurement of the physiological parameter;
receive, from a user, an indication of access an alarm hold initiator for a parameter-specific alarm suspension hold period of time corresponding to the physiological parameter, the parameter-specific alarm suspension hold period of time being selected from one of a plurality of parameter-specific alarm suspension hold periods of time, the parameter-specific alarm suspension hold period of time being different from at least one other parameter-specific alarm suspension hold period of time corresponding to at least one other physiological parameter for which the one or more processors are configured to determine at least one measurement;
activate an alarm in response to determining that an alarm activation threshold has been satisfied by the physiological parameter measurement;
receive determine that the alarm hold initiator indicates to hold an indication of an alarm suspension indication for the alarm condition; and
in response to receiving determining that the alarm hold initiator indicates to hold the indication of the alarm suspension indication, suspend hold the indication of the alarm for the indicated parameter-specific alarm suspension hold period of time; and
subsequent to the parameter-specific alarm hold period of time passing, activate the indication of the alarm while the measurement of the physiological parameter satisfies the activation threshold.
2. The physiological measurement system of claim 1, wherein the one or more processors are further configured to:
provide a user interface to the user including at least a plurality of user-selectable elements, each of the plurality of user-selectable elements corresponding to one of the plurality of parameter-specific alarm suspension hold periods of time.
3. The physiological measurement system of claim 2, wherein providing the user interface further includes:
constructing a pop-up window for a display; and
displaying the plurality of user-selectable elements in the pop-up window.
4. The physiological measurement system of claim 3, wherein the plurality of user-selectable elements are configured to allow a user to select a specific one of the plurality of parameter-specific alarm suspension hold periods of time.
5. The physiological measurement system of claim 4, wherein the a selected parameter-specific alarm suspension hold period of time is selected by selection of one of the plurality of user-selectable elements.
6. The physiological measurement system of claim 1, wherein the one or more processors are further configured to:
associate the a selected parameter-specific alarm hold period of time is with the physiological parameter.
7. The physiological measurement system of claim 6, wherein the selected parameter-specific alarm hold period of time is stored in a memory device in communication with the one or more processors.
8. The physiological measurement system of claim 1, wherein the one or more processors are further configured to:
determine a measurement of a second physiological parameter measurement based at least in part upon the signal, the second physiological parameter being different from the physiological parameter;
determine whether a second alarm condition exists by determining whether a second activation threshold has been satisfied by the measurement of the second physiological parameter;
receive, from the user, access a second indication of alarm hold initiator for a second parameter-specific alarm suspension hold period of time corresponding to the second physiological parameter, the second parameter-specific alarm suspension hold period of time being selected from one of a second plurality of parameter-specific alarm suspension hold periods of time, the second parameter-specific alarm hold period of time being different from the parameter-specific alarm hold period of time corresponding to the physiological parameter;
activate a second alarm in response to determining a second alarm activation threshold has been satisfied by the second physiological parameter measurement determine that the second alarm hold initiator indicates to hold an indication of a second alarm for the second alarm condition; and
in response to receiving determining that the second alarm hold initiator indicates to hold the indication of the second alarm suspension indication, suspend hold the indication of the second alarm for the indicated second parameter-specific alarm suspension hold period of time; and
subsequent to the second parameter-specific alarm hold period of time passing, activate the indication of the second alarm while the measurement of the second physiological parameter satisfies the second activation threshold.
9. The physiological measurement system of claim 8, wherein the one or more processors are further configured to:
provide a user interface to the user including at least a first plurality of user-selectable elements and a second plurality of user-selectable elements, wherein each of the first plurality of user-selectable elements corresponds to one of the plurality of parameter-specific alarm suspension hold periods of time, and each of the second plurality of user-selectable element corresponds to one of the second plurality of parameter-specific alarm suspension hold periods of time.
10. The physiological measurement system of claim 9, wherein the one or more processors are further configured to:
construct a pop-up window for a display; and
display both the first and second plurality of user-selectable elements in the pop-up window.
11. The physiological measurement system of claim 10, wherein the a selected first parameter-specific alarm suspension hold period of time is selected by selection of one of the first plurality of user-selectable elements, and the a selected second parameter-specific alarm suspension hold period of time is selected by selection of one of the second plurality of user-selectable elements.
12. The physiological measurement system of claim 11, wherein the at least one of the first plurality of parameter-specific alarm suspension hold periods of time is different from any of the second plurality of parameter-specific alarm suspension hold periods of time.
13. An A method comprising:
measuring a first physiological parameter and a second physiological parameter using a patient monitoring device, the patient monitoring device including a processor and a memory device configured to store a parameter-specific alarm suspension period of time;
receiving accessing, from a user the memory device, an indication of a first alarm hold initiator for a first parameter-specific alarm suspension hold period of time corresponding to the first physiological parameter and a second alarm hold initiator for a second parameter-specific alarm hold period of time corresponding to the second physiological parameter, the parameter-specific alarm suspension period of time being selected from a plurality of parameter-specific alarm suspension periods of time, the first parameter-specific alarm suspension hold period of time being different from at least one other the second parameter-specific alarm suspension hold period of time corresponding to at least one other physiological parameter; activating an alarm in response to determining an alarm activation threshold has been satisfied by the physiological parameter measurement;
receiving an determining that the first alarm hold initiator indicates to hold a first indication of a first alarm suspension indication for a first alarm condition for the first physiological parameter; and
in response to receiving determining that the first alarm hold initiator indicates to hold the first indication of the first alarm suspension indication, suspending holding the first indication of the first alarm for the indicated first parameter-specific alarm suspension hold period of time; and
subsequent to the first parameter-specific alarm hold period of time passing, activating the first indication of the first alarm.
14. The method of claim 13, wherein the first alarm includes an audible component and a visual component, and wherein suspending holding the first indication of the first alarm comprises suspending holding the audible component and not suspending holding the visual component.
15. The method of claim 13 further comprising:
providing a user interface to the user including at least a plurality of user-selectable elements, each of the plurality of user-selectable elements corresponding to one of the a plurality of parameter-specific alarm suspension hold periods of time,
wherein the plurality of parameter-specific alarm hold periods of time comprise the first parameter specific alarm hold period of time.
16. The method of claim 15 further comprising:
constructing a pop-up window for a display; and
displaying the plurality of user-selectable elements in the pop-up window.
17. The method of claim 16, wherein the a selected parameter-specific alarm suspension hold period of time is selected by selection of one of the plurality of user-selectable elements.
18. A physiological measurement system comprising:
a physiological sensor means for outputting configured to output a signal responsive to a noninvasive measurement of attenuated light transmitted through a tissue site physiological condition of a patient;
a memory configured to store a first alarm activation threshold; and
a processing means one or more processors in communication with the physiological sensor means and configured to:
determine a first measurement of a the first measured physiological parameter based at least in part upon the signal;
determine whether a first alarm condition exists by determining whether the first alarm activation threshold has been satisfied by the first measurement of the first measured physiological parameter;
receive, from a user, an indication of a access a first alarm hold initiator for a first parameter-specific alarm suspension hold period of time corresponding to the first measured physiological parameter, the parameter-specific alarm suspension period of time being selected from a plurality of parameter-specific alarm suspension periods of time, the first parameter-specific alarm suspension hold period of time being different from at least one other a second parameter-specific alarm suspension hold period of time corresponding to at least one other a second measured physiological parameter for which the one or more processors are configured to determine a second measurement;
activate an alarm in response to determining an alarm activation threshold has been satisfied by the physiological parameter measurement;
receive an determine that the first alarm hold initiator indicates to hold activation of a first alarm suspension indication for the first alarm condition; and
in response to receiving determining that the first alarm hold initiator indicates to hold activation of the first alarm suspension indication, suspend hold activation of the first alarm for the indicated first parameter-specific alarm suspension hold period of time; and
activate the first alarm.
19. The physiological measurement system of claim 18, wherein the processing means is one or more processors are further configured to:
determine a the second physiological parameter measurement based at least in part upon the signal;
determine whether a second alarm condition exists by determining whether a second alarm activation threshold has been satisfied by the second measurement;
receive, from the user, access a second indication of a alarm hold initiator for the second parameter-specific alarm suspension hold period of time corresponding to the second physiological parameter, the second parameter-specific alarm suspension period of time being selected from a second plurality of parameter-specific alarm suspension periods of time; activate a second alarm in response to determining a second alarm activation threshold has been satisfied by the second physiological parameter measurement;
determine that the second alarm hold initiator indicates to hold activation of a second alarm for the second alarm condition; and
in response to receiving determining that the second alarm hold initiator indicates to hold activation of the second alarm suspension indication, suspend hold activation of the second alarm for the indicated second parameter-specific alarm suspension hold period of time.
20. The physiological measurement system of claim 19, wherein the processing means is one or more processors are further configured to:
provide a user interface to the user including at least a first plurality of user-selectable elements and a second plurality of user-selectable elements, wherein each of the first plurality of user-selectable elements corresponds to one of the a first plurality of parameter-specific alarm suspension hold periods of time, and each of the second plurality of user-selectable element elements corresponds to one of the a second plurality of parameter-specific alarm suspension hold periods of time,
wherein the first plurality of parameter-specific alarm hold periods of time comprise the first parameter-specific alarm hold period of time, and the second plurality of parameter-specific alarm hold periods of time comprise the second parameter-specific alarm hold period of time.
21. The physiological measurement system of claim 20, wherein the a selected first parameter-specific alarm suspension hold period of time is selected by selection of one of the first plurality of user-selectable elements, and the a selected second parameter-specific alarm suspension hold period of time is selected by selection of one of the second plurality of user-selectable elements.
22. The physiological measurement system of claim 21, wherein at least one of the first plurality of parameter-specific alarm suspension hold periods of time is different from any of the second plurality of parameter-specific alarm suspension hold periods of time.
23. The physiological measurement system of claim 1, wherein the one or more processors are further configured to modify a visual indicator for the parameter-specific alarm hold period of time.
24. The physiological measurement system of claim 1, wherein the physiological parameter comprises one of an oxygen saturation, a pulse rate, a perfusion index, a pleth variability index, a carboxyhemoglobin, a methemoglobin, or a total hemoglobin.
Patent Citations (766)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US4639718(A) | 1987-01-01 | Gasper | Examiner |
| US4653498(A) | 1987-03-01 | New et al. | Applicant |
| US4960128(A) | 1990-10-01 | Gordon et al. | Applicant |
| US4964408(A) | 1990-10-01 | Hink et al. | Applicant |
| US5041187(A) | 1991-08-01 | Hink et al. | Applicant |
| US5069213(A) | 1991-12-01 | Polczynski | Applicant |
| US5111817(A) | 1992-05-01 | Clark et al. | Applicant |
| US5163438(A) | 1992-11-01 | Gordon et al. | Applicant |
| US5226417(A) | 1993-07-01 | Swedlow et al. | Applicant |
| US5253645(A) | 1993-10-01 | Friedman et al. | Applicant |
| US5253646(A) | 1993-10-01 | Delpy et al. | Applicant |
| US5319355(A) | 1994-06-01 | Russek | Applicant |
| US5319363(A) | 1994-06-01 | Welch | Examiner |
| US5337744(A) | 1994-08-01 | Branigan | Applicant |
| US5341805(A) | 1994-08-01 | Stavridi et al. | Applicant |
| USD353195(S) | 1994-12-01 | Savage et al. | Applicant |
| USD353196(S) | 1994-12-01 | Savage et al. | Applicant |
| US5377676(A) | 1995-01-01 | Vari et al. | Applicant |
| USD359546(S) | 1995-06-01 | Savage et al. | Applicant |
| US5431170(A) | 1995-07-01 | Mathews | Applicant |
| USD361840(S) | 1995-08-01 | Savage et al. | Applicant |
| USD362063(S) | 1995-09-01 | Savage et al. | Applicant |
| US5452717(A) | 1995-09-01 | Branigan et al. | Applicant |
| USD363120(S) | 1995-10-01 | Savage et al. | Applicant |
| US5456252(A) | 1995-10-01 | Vari et al. | Applicant |
| US5479934(A) | 1996-01-01 | Imran | Applicant |
| US5482036(A) | 1996-01-01 | Diab et al. | Applicant |
| US5490505(A) | 1996-02-01 | Diab et al. | Applicant |
| US5494043(A) | 1996-02-01 | O'Sullivan et al. | Applicant |
| US5533511(A) | 1996-07-01 | Kaspari et al. | Applicant |
| US5534851(A) | 1996-07-01 | Russek | Applicant |
| US5561275(A) | 1996-10-01 | Savage et al. | Applicant |
| US5562002(A) | 1996-10-01 | Lalin | Applicant |
| US5590649(A) | 1997-01-01 | Caro et al. | Applicant |
| US5602924(A) | 1997-02-01 | Durand et al. | Applicant |
| US5632272(A) | 1997-05-01 | Diab et al. | Applicant |
| US5638816(A) | 1997-06-01 | Kiani-Azarbayjany et al. | Applicant |
| US5638818(A) | 1997-06-01 | Diab et al. | Applicant |
| US5645440(A) | 1997-07-01 | Tobler et al. | Applicant |
| US5685299(A) | 1997-11-01 | Diab et al. | Applicant |
| USD393830(S) | 1998-04-01 | Tobler et al. | Applicant |
| US5743262(A) | 1998-04-01 | Lepper, Jr. et al. | Applicant |
| US5758644(A) | 1998-06-01 | Diab et al. | Applicant |
| US5760910(A) | 1998-06-01 | Lepper, Jr. et al. | Applicant |
| US5769785(A) | 1998-06-01 | Diab et al. | Applicant |
| US5782757(A) | 1998-07-01 | Diab et al. | Applicant |
| US5785659(A) | 1998-07-01 | Caro et al. | Applicant |
| US5791347(A) | 1998-08-01 | Flaherty et al. | Applicant |
| US5810734(A) | 1998-09-01 | Caro et al. | Applicant |
| US5823950(A) | 1998-10-01 | Diab et al. | Applicant |
| US5830131(A) | 1998-11-01 | Caro et al. | Applicant |
| US5833618(A) | 1998-11-01 | Caro et al. | Applicant |
| US5860919(A) | 1999-01-01 | Kiani-Azarbayjany et al. | Applicant |
| US5876348(A) | 1999-03-01 | Sugo et al. | Applicant |
| US5890929(A) | 1999-04-01 | Mills et al. | Applicant |
| US5904654(A) | 1999-05-01 | Wohltmann et al. | Applicant |
| US5919134(A) | 1999-07-01 | Diab | Applicant |
| US5934925(A) | 1999-08-01 | Tobler et al. | Applicant |
| US5940182(A) | 1999-08-01 | Lepper, Jr. et al. | Applicant |
| US5995855(A) | 1999-11-01 | Kiani et al. | Applicant |
| US5997343(A) | 1999-12-01 | Mills et al. | Applicant |
| US6002952(A) | 1999-12-01 | Diab et al. | Applicant |
| US6005658(A) | 1999-12-01 | Kaluza et al. | Applicant |
| US6011986(A) | 2000-01-01 | Diab et al. | Applicant |
| US6027452(A) | 2000-02-01 | Flaherty et al. | Applicant |
| US6036642(A) | 2000-03-01 | Diab et al. | Applicant |
| US6045509(A) | 2000-04-01 | Caro et al. | Applicant |
| US6050951(A) | 2000-04-01 | Friedman et al. | Applicant |
| US6067462(A) | 2000-05-01 | Diab et al. | Applicant |
| US6081735(A) | 2000-06-01 | Diab et al. | Applicant |
| US6088607(A) | 2000-07-01 | Diab et al. | Applicant |
| US6110522(A) | 2000-08-01 | Lepper, Jr. et al. | Applicant |
| US6124597(A) | 2000-09-01 | Shehada | Applicant |
| US6128521(A) | 2000-10-01 | Marro et al. | Applicant |
| US6129675(A) | 2000-10-01 | Jay | Applicant |
| US6144868(A) | 2000-11-01 | Parker | Applicant |
| US6151516(A) | 2000-11-01 | Kiani-Azarbayjany et al. | Applicant |
| US6152754(A) | 2000-11-01 | Gerhardt et al. | Applicant |
| US6157850(A) | 2000-12-01 | Diab et al. | Applicant |
| US6165005(A) | 2000-12-01 | Mills et al. | Applicant |
| US6184521(B1) | 2001-02-01 | Coffin, IV et al. | Applicant |
| US6190325(B1) | 2001-02-01 | Narimatsu | Applicant |
| US6206830(B1) | 2001-03-01 | Diab et al. | Applicant |
| US6229856(B1) | 2001-05-01 | Diab et al. | Applicant |
| US6232609(B1) | 2001-05-01 | Snyder et al. | Applicant |
| US6236872(B1) | 2001-05-01 | Diab et al. | Applicant |
| US6241683(B1) | 2001-06-01 | Macklem et al. | Applicant |
| US6253097(B1) | 2001-06-01 | Aronow et al. | Applicant |
| US6256523(B1) | 2001-07-01 | Diab et al. | Applicant |
| US6263222(B1) | 2001-07-01 | Diab et al. | Applicant |
| US6278522(B1) | 2001-08-01 | Lepper, Jr. et al. | Applicant |
| US6280213(B1) | 2001-08-01 | Tobler et al. | Applicant |
| US6285896(B1) | 2001-09-01 | Tobler et al. | Applicant |
| US6301493(B1) | 2001-10-01 | Marro et al. | Applicant |
| US6317627(B1) | 2001-11-01 | Ennen et al. | Applicant |
| US6321100(B1) | 2001-11-01 | Parker | Applicant |
| US6325761(B1) | 2001-12-01 | Jay | Applicant |
| US6334065(B1) | 2001-12-01 | Al-Ali et al. | Applicant |
| US6343224(B1) | 2002-01-01 | Parker | Applicant |
| US6349228(B1) | 2002-02-01 | Kiani et al. | Applicant |
| US6360114(B1) | 2002-03-01 | Diab et al. | Applicant |
| US6368283(B1) | 2002-04-01 | Xu et al. | Applicant |
| US6371921(B1) | 2002-04-01 | Caro et al. | Applicant |
| US6377829(B1) | 2002-04-01 | Al-Ali | Applicant |
| US6388240(B2) | 2002-05-01 | Schulz et al. | Applicant |
| US6397091(B2) | 2002-05-01 | Diab et al. | Applicant |
| US6430437(B1) | 2002-08-01 | Marro | Applicant |
| US6430525(B1) | 2002-08-01 | Weber et al. | Applicant |
| US6463311(B1) | 2002-10-01 | Diab | Applicant |
| US6470199(B1) | 2002-10-01 | Kopotic et al. | Applicant |
| US6501975(B2) | 2002-12-01 | Diab et al. | Applicant |
| US6505059(B1) | 2003-01-01 | Kollias et al. | Applicant |
| US6515273(B2) | 2003-02-01 | Al-Ali | Applicant |
| US6519487(B1) | 2003-02-01 | Parker | Applicant |
| US6525386(B1) | 2003-02-01 | Mills et al. | Applicant |
| US6526300(B1) | 2003-02-01 | Kiani et al. | Applicant |
| US6541756(B2) | 2003-04-01 | Schulz et al. | Applicant |
| US6542764(B1) | 2003-04-01 | Al-Ali et al. | Applicant |
| US6553242(B1) | 2003-04-01 | Sarussi | Applicant |
| US6580086(B1) | 2003-06-01 | Schulz et al. | Applicant |
| US6584336(B1) | 2003-06-01 | Ali et al. | Applicant |
| US6595316(B2) | 2003-07-01 | Cybulski et al. | Applicant |
| US6597932(B2) | 2003-07-01 | Tian et al. | Applicant |
| US6597933(B2) | 2003-07-01 | Kiani et al. | Applicant |
| US6606511(B1) | 2003-08-01 | Ali et al. | Applicant |
| US6632181(B2) | 2003-10-01 | Flaherty et al. | Applicant |
| US6639668(B1) | 2003-10-01 | Trepagnier | Applicant |
| US6640116(B2) | 2003-10-01 | Diab | Applicant |
| US6643530(B2) | 2003-11-01 | Diab et al. | Applicant |
| US6645155(B2) | 2003-11-01 | Inukai et al. | Applicant |
| US6650917(B2) | 2003-11-01 | Diab et al. | Applicant |
| US6654624(B2) | 2003-11-01 | Diab et al. | Applicant |
| US6658276(B2) | 2003-12-01 | Kianl et al. | Examiner |
| US6661161(B1) | 2003-12-01 | Lanzo et al. | Applicant |
| US6671531(B2) | 2003-12-01 | Al-Ali et al. | Applicant |
| US6678543(B2) | 2004-01-01 | Diab et al. | Applicant |
| US6684090(B2) | 2004-01-01 | Ali et al. | Applicant |
| US6684091(B2) | 2004-01-01 | Parker | Applicant |
| US6697656(B1) | 2004-02-01 | Al-Ali | Applicant |
| US6697657(B1) | 2004-02-01 | Shehada et al. | Applicant |
| US6697658(B2) | 2004-02-01 | Al-Ali | Applicant |
| USRE38476(E) | 2004-03-01 | Diab et al. | Applicant |
| US6699194(B1) | 2004-03-01 | Diab et al. | Applicant |
| US6714804(B2) | 2004-03-01 | Al-Ali et al. | Applicant |
| USRE38492(E) | 2004-04-01 | Diab et al. | Applicant |
| US6721582(B2) | 2004-04-01 | Trepagnier et al. | Applicant |
| US6721585(B1) | 2004-04-01 | Parker | Applicant |
| US6725075(B2) | 2004-04-01 | Al-Ali | Applicant |
| US6728560(B2) | 2004-04-01 | Kollias et al. | Applicant |
| US6735459(B2) | 2004-05-01 | Parker | Applicant |
| US6745060(B2) | 2004-06-01 | Diab et al. | Applicant |
| US6754516(B2) | 2004-06-01 | Mannheimer | Applicant |
| US6760607(B2) | 2004-07-01 | Al-Ali | Applicant |
| US6770028(B1) | 2004-08-01 | Ali et al. | Applicant |
| US6771994(B2) | 2004-08-01 | Kiani et al. | Applicant |
| US6792300(B1) | 2004-09-01 | Diab et al. | Applicant |
| US6813511(B2) | 2004-11-01 | Diab et al. | Applicant |
| US6816741(B2) | 2004-11-01 | Diab | Applicant |
| US6822564(B2) | 2004-11-01 | Al-Ali | Applicant |
| US6826419(B2) | 2004-11-01 | Diab et al. | Applicant |
| US6830711(B2) | 2004-12-01 | Mills et al. | Applicant |
| US6850787(B2) | 2005-02-01 | Weber et al. | Applicant |
| US6850788(B2) | 2005-02-01 | Al-Ali | Applicant |
| US6852083(B2) | 2005-02-01 | Caro et al. | Applicant |
| US6861639(B2) | 2005-03-01 | Al-Ali | Applicant |
| US6898452(B2) | 2005-05-01 | Al-Ali et al. | Applicant |
| US6920345(B2) | 2005-07-01 | Al-Ali et al. | Applicant |
| US6931268(B1) | 2005-08-01 | Kiani-Azarbayjany et al. | Applicant |
| US6934570(B2) | 2005-08-01 | Kiani et al. | Applicant |
| US6939305(B2) | 2005-09-01 | Flaherty et al. | Applicant |
| US6943348(B1) | 2005-09-01 | Coffin, IV | Applicant |
| US6950687(B2) | 2005-09-01 | Al-Ali | Applicant |
| US6961598(B2) | 2005-11-01 | Diab | Applicant |
| US6970792(B1) | 2005-11-01 | Diab | Applicant |
| US6979812(B2) | 2005-12-01 | Al-Ali | Applicant |
| US6985764(B2) | 2006-01-01 | Mason et al. | Applicant |
| US6993371(B2) | 2006-01-01 | Kiani et al. | Applicant |
| US6996427(B2) | 2006-02-01 | Ali et al. | Applicant |
| US6999904(B2) | 2006-02-01 | Weber et al. | Applicant |
| US7003338(B2) | 2006-02-01 | Weber et al. | Applicant |
| US7003339(B2) | 2006-02-01 | Diab et al. | Applicant |
| US7015451(B2) | 2006-03-01 | Dalke et al. | Applicant |
| US7024233(B2) | 2006-04-01 | Ali et al. | Applicant |
| US7027849(B2) | 2006-04-01 | Al-Ali | Applicant |
| US7030749(B2) | 2006-04-01 | Al-Ali | Applicant |
| US7039449(B2) | 2006-05-01 | Al-Ali | Applicant |
| US7041060(B2) | 2006-05-01 | Flaherty et al. | Applicant |
| US7044918(B2) | 2006-05-01 | Diab | Applicant |
| US7067893(B2) | 2006-06-01 | Mills et al. | Applicant |
| US7096052(B2) | 2006-08-01 | Mason et al. | Applicant |
| US7096054(B2) | 2006-08-01 | Abdul-Hafiz et al. | Applicant |
| US7123950(B2) | 2006-10-01 | Mannheimer | Applicant |
| US7132641(B2) | 2006-11-01 | Schulz et al. | Applicant |
| US7142901(B2) | 2006-11-01 | Kiani et al. | Applicant |
| US7149561(B2) | 2006-12-01 | Diab | Applicant |
| US7186966(B2) | 2007-03-01 | Al-Ali | Applicant |
| US7190261(B2) | 2007-03-01 | Al-Ali | Applicant |
| US7215984(B2) | 2007-05-01 | Diab | Applicant |
| US7215986(B2) | 2007-05-01 | Diab | Applicant |
| US7221971(B2) | 2007-05-01 | Diab | Applicant |
| US7225006(B2) | 2007-05-01 | Al-Ali et al. | Applicant |
| US7225007(B2) | 2007-05-01 | Al-Ali | Applicant |
| USRE39672(E) | 2007-06-01 | Shehada et al. | Applicant |
| US7239905(B2) | 2007-07-01 | Kiani-Azarbayjany et al. | Applicant |
| US7245953(B1) | 2007-07-01 | Parker | Applicant |
| US7254429(B2) | 2007-08-01 | Schurman et al. | Applicant |
| US7254431(B2) | 2007-08-01 | Al-Ali | Applicant |
| US7254433(B2) | 2007-08-01 | Diab et al. | Applicant |
| US7254434(B2) | 2007-08-01 | Schulz et al. | Applicant |
| US7272425(B2) | 2007-09-01 | Al-Ali | Applicant |
| US7274955(B2) | 2007-09-01 | Kiani et al. | Applicant |
| USD554263(S) | 2007-10-01 | Al-Ali | Applicant |
| US7280858(B2) | 2007-10-01 | Al-Ali et al. | Applicant |
| US7289835(B2) | 2007-10-01 | Mansfield et al. | Applicant |
| US7292883(B2) | 2007-11-01 | De Felice et al. | Applicant |
| US7295866(B2) | 2007-11-01 | Al-Ali | Applicant |
| US7328053(B1) | 2008-02-01 | Diab et al. | Applicant |
| US7332784(B2) | 2008-02-01 | Mills et al. | Applicant |
| US7340287(B2) | 2008-03-01 | Mason et al. | Applicant |
| US7341559(B2) | 2008-03-01 | Schulz et al. | Applicant |
| US7343186(B2) | 2008-03-01 | Lamego et al. | Applicant |
| USD566282(S) | 2008-04-01 | Al-Ali et al. | Applicant |
| US7355512(B1) | 2008-04-01 | Al-Ali | Applicant |
| US7356365(B2) | 2008-04-01 | Schurman | Applicant |
| US7371981(B2) | 2008-05-01 | Abdul-Hafiz | Applicant |
| US7373193(B2) | 2008-05-01 | Al-Ali et al. | Applicant |
| US7373194(B2) | 2008-05-01 | Weber et al. | Applicant |
| US7376453(B1) | 2008-05-01 | Diab et al. | Applicant |
| US7377794(B2) | 2008-05-01 | Al-Ali et al. | Applicant |
| US7377899(B2) | 2008-05-01 | Weber et al. | Applicant |
| US7383070(B2) | 2008-06-01 | Diab et al. | Applicant |
| US7415297(B2) | 2008-08-01 | Al-Ali et al. | Applicant |
| US7428432(B2) | 2008-09-01 | Ali et al. | Applicant |
| US7438683(B2) | 2008-10-01 | Al-Ali et al. | Applicant |
| US7440787(B2) | 2008-10-01 | Diab | Applicant |
| US7454240(B2) | 2008-11-01 | Diab et al. | Applicant |
| US7467002(B2) | 2008-12-01 | Weber et al. | Applicant |
| US7469157(B2) | 2008-12-01 | Diab et al. | Applicant |
| US7471969(B2) | 2008-12-01 | Diab et al. | Applicant |
| US7471971(B2) | 2008-12-01 | Diab et al. | Applicant |
| US7483729(B2) | 2009-01-01 | Al-Ali et al. | Applicant |
| US7483730(B2) | 2009-01-01 | Diab et al. | Applicant |
| US7489958(B2) | 2009-02-01 | Diab et al. | Applicant |
| US7496391(B2) | 2009-02-01 | Diab et al. | Applicant |
| US7496393(B2) | 2009-02-01 | Diab et al. | Applicant |
| USD587657(S) | 2009-03-01 | Al-Ali et al. | Applicant |
| US7499741(B2) | 2009-03-01 | Diab et al. | Applicant |
| US7499835(B2) | 2009-03-01 | Weber et al. | Applicant |
| US7500950(B2) | 2009-03-01 | Al-Ali et al. | Applicant |
| US7509154(B2) | 2009-03-01 | Diab et al. | Applicant |
| US7509494(B2) | 2009-03-01 | Al-Ali | Applicant |
| US7510849(B2) | 2009-03-01 | Schurman et al. | Applicant |
| US7526328(B2) | 2009-04-01 | Diab et al. | Applicant |
| US7530942(B1) | 2009-05-01 | Diab | Applicant |
| US7530949(B2) | 2009-05-01 | Al Ali et al. | Applicant |
| US7530955(B2) | 2009-05-01 | Diab et al. | Applicant |
| US7563110(B2) | 2009-07-01 | Al-Ali et al. | Applicant |
| US7596398(B2) | 2009-09-01 | Al-Ali et al. | Applicant |
| US7618375(B2) | 2009-11-01 | Flaherty et al. | Applicant |
| USD606659(S) | 2009-12-01 | Kiani et al. | Applicant |
| US7647083(B2) | 2010-01-01 | Al-Ali et al. | Applicant |
| USD609193(S) | 2010-02-01 | Al-Ali et al. | Applicant |
| USD614305(S) | 2010-04-01 | Al-Ali et al. | Applicant |
| USRE41317(E) | 2010-05-01 | Parker | Applicant |
| US7729733(B2) | 2010-06-01 | Al-Ali et al. | Applicant |
| US7734320(B2) | 2010-06-01 | Al-Ali | Applicant |
| US7761127(B2) | 2010-07-01 | Al-Ali et al. | Applicant |
| US7761128(B2) | 2010-07-01 | Al-Ali et al. | Applicant |
| US7764982(B2) | 2010-07-01 | Dalke et al. | Applicant |
| USD621516(S) | 2010-08-01 | Kiani et al. | Applicant |
| US7791155(B2) | 2010-09-01 | Diab | Applicant |
| US7801581(B2) | 2010-09-01 | Diab | Applicant |
| US7822452(B2) | 2010-10-01 | Schurman et al. | Applicant |
| USRE41912(E) | 2010-11-01 | Parker | Applicant |
| US7844313(B2) | 2010-11-01 | Kiani et al. | Applicant |
| US7844314(B2) | 2010-11-01 | Al-Ali | Applicant |
| US7844315(B2) | 2010-11-01 | Al-Ali | Applicant |
| US7865222(B2) | 2011-01-01 | Weber et al. | Applicant |
| US7873497(B2) | 2011-01-01 | Weber et al. | Applicant |
| US7880606(B2) | 2011-02-01 | Al-Ali | Applicant |
| US7880626(B2) | 2011-02-01 | Al-Ali et al. | Applicant |
| US7891355(B2) | 2011-02-01 | Al-Ali et al. | Applicant |
| US7894868(B2) | 2011-02-01 | Al-Ali et al. | Applicant |
| US7899507(B2) | 2011-03-01 | Al-Ali et al. | Applicant |
| US7899518(B2) | 2011-03-01 | Trepagnier et al. | Applicant |
| US7904132(B2) | 2011-03-01 | Weber et al. | Applicant |
| US7909772(B2) | 2011-03-01 | Popov et al. | Applicant |
| US7910875(B2) | 2011-03-01 | Al-Ali | Applicant |
| US7919713(B2) | 2011-04-01 | Al-Ali et al. | Applicant |
| US7937128(B2) | 2011-05-01 | Al-Ali | Applicant |
| US7937129(B2) | 2011-05-01 | Mason et al. | Applicant |
| US7937130(B2) | 2011-05-01 | Diab et al. | Applicant |
| US7941199(B2) | 2011-05-01 | Kiani | Applicant |
| US7951086(B2) | 2011-05-01 | Flaherty et al. | Applicant |
| US7957780(B2) | 2011-06-01 | Lamego et al. | Applicant |
| US7962188(B2) | 2011-06-01 | Kiani et al. | Applicant |
| US7962190(B1) | 2011-06-01 | Diab et al. | Applicant |
| US7976472(B2) | 2011-07-01 | Kiani | Applicant |
| US7988637(B2) | 2011-08-01 | Diab | Applicant |
| US7990382(B2) | 2011-08-01 | Kiani | Applicant |
| US7991446(B2) | 2011-08-01 | Ali et al. | Applicant |
| US8000761(B2) | 2011-08-01 | Al-Ali | Applicant |
| US8008088(B2) | 2011-08-01 | Bellott et al. | Applicant |
| USRE42753(E) | 2011-09-01 | Kiani-Azarbayjany et al. | Applicant |
| US8019400(B2) | 2011-09-01 | Diab et al. | Applicant |
| US8028701(B2) | 2011-10-01 | Al-Ali et al. | Applicant |
| US8029765(B2) | 2011-10-01 | Bellott et al. | Applicant |
| US8036727(B2) | 2011-10-01 | Schurman et al. | Applicant |
| US8036728(B2) | 2011-10-01 | Diab et al. | Applicant |
| US8046040(B2) | 2011-10-01 | Ali et al. | Applicant |
| US8046041(B2) | 2011-10-01 | Diab et al. | Applicant |
| US8046042(B2) | 2011-10-01 | Diab et al. | Applicant |
| US8048040(B2) | 2011-11-01 | Kiani | Applicant |
| US8050728(B2) | 2011-11-01 | Al-Ali et al. | Applicant |
| USRE43169(E) | 2012-02-01 | Parker | Applicant |
| US8118620(B2) | 2012-02-01 | Al-Ali et al. | Applicant |
| US8126528(B2) | 2012-02-01 | Diab et al. | Applicant |
| US8128572(B2) | 2012-03-01 | Diab et al. | Applicant |
| US8130105(B2) | 2012-03-01 | Al-Ali et al. | Applicant |
| US8145287(B2) | 2012-03-01 | Diab et al. | Applicant |
| US8150487(B2) | 2012-04-01 | Diab et al. | Applicant |
| US8175672(B2) | 2012-05-01 | Parker | Applicant |
| US8180420(B2) | 2012-05-01 | Diab et al. | Applicant |
| US8182443(B1) | 2012-05-01 | Kiani | Applicant |
| US8185180(B2) | 2012-05-01 | Diab et al. | Applicant |
| US8190223(B2) | 2012-05-01 | Al-Ali et al. | Applicant |
| US8190227(B2) | 2012-05-01 | Diab et al. | Applicant |
| US8203438(B2) | 2012-06-01 | Kiani et al. | Examiner |
| US8203704(B2) | 2012-06-01 | Merritt et al. | Applicant |
| US8204566(B2) | 2012-06-01 | Schurman et al. | Applicant |
| US8219172(B2) | 2012-07-01 | Schurman et al. | Applicant |
| US8224411(B2) | 2012-07-01 | Al-Ali et al. | Applicant |
| US8228181(B2) | 2012-07-01 | Al-Ali | Applicant |
| US8229533(B2) | 2012-07-01 | Diab et al. | Applicant |
| US8233955(B2) | 2012-07-01 | Al-Ali et al. | Applicant |
| US8244325(B2) | 2012-08-01 | Al-Ali et al. | Applicant |
| US8255026(B1) | 2012-08-01 | Al-Ali | Applicant |
| US8255027(B2) | 2012-08-01 | Al-Ali et al. | Applicant |
| US8255028(B2) | 2012-08-01 | Al-Ali et al. | Applicant |
| US8260577(B2) | 2012-09-01 | Weber et al. | Applicant |
| US8265723(B1) | 2012-09-01 | McHale et al. | Applicant |
| US8274360(B2) | 2012-09-01 | Sampath et al. | Applicant |
| US8301217(B2) | 2012-10-01 | Al-Ali et al. | Applicant |
| US8306596(B2) | 2012-11-01 | Schurman et al. | Applicant |
| US8310336(B2) | 2012-11-01 | Muhsin et al. | Applicant |
| US8315683(B2) | 2012-11-01 | Al-Ali et al. | Applicant |
| USRE43860(E) | 2012-12-01 | Parker | Applicant |
| US8337403(B2) | 2012-12-01 | Al-Ali et al. | Applicant |
| US8346330(B2) | 2013-01-01 | Lamego | Applicant |
| US8353842(B2) | 2013-01-01 | Al-Ali et al. | Applicant |
| US8355766(B2) | 2013-01-01 | MacNeish, III et al. | Applicant |
| US8359080(B2) | 2013-01-01 | Diab et al. | Applicant |
| US8364223(B2) | 2013-01-01 | Al-Ali et al. | Applicant |
| US8364226(B2) | 2013-01-01 | Diab et al. | Applicant |
| US8374665(B2) | 2013-02-01 | Lamego | Applicant |
| US8385995(B2) | 2013-02-01 | Al-Ali et al. | Applicant |
| US8385996(B2) | 2013-02-01 | Smith et al. | Applicant |
| US8388353(B2) | 2013-03-01 | Kiani et al. | Applicant |
| US8399822(B2) | 2013-03-01 | Al-Ali | Applicant |
| US8401602(B2) | 2013-03-01 | Kiani | Applicant |
| US8401607(B2) | 2013-03-01 | Mannheimer | Applicant |
| US8405608(B2) | 2013-03-01 | Al-Ali et al. | Applicant |
| US8414499(B2) | 2013-04-01 | Al-Ali et al. | Applicant |
| US8418524(B2) | 2013-04-01 | Al-Ali | Applicant |
| US8423106(B2) | 2013-04-01 | Lamego et al. | Applicant |
| US8428967(B2) | 2013-04-01 | Olsen et al. | Applicant |
| US8430817(B1) | 2013-04-01 | Al-Ali et al. | Applicant |
| US8437825(B2) | 2013-05-01 | Dalvi et al. | Applicant |
| US8455290(B2) | 2013-06-01 | Siskavich | Applicant |
| US8457703(B2) | 2013-06-01 | Al-Ali | Applicant |
| US8457707(B2) | 2013-06-01 | Kiani | Applicant |
| US8463349(B2) | 2013-06-01 | Diab et al. | Applicant |
| US8466286(B2) | 2013-06-01 | Bellott et al. | Applicant |
| US8471713(B2) | 2013-06-01 | Poeze et al. | Applicant |
| US8473020(B2) | 2013-06-01 | Kiani et al. | Applicant |
| US8483787(B2) | 2013-07-01 | Al-Ali et al. | Applicant |
| US8489364(B2) | 2013-07-01 | Weber et al. | Applicant |
| US8498684(B2) | 2013-07-01 | Weber et al. | Applicant |
| US8504128(B2) | 2013-08-01 | Blank et al. | Applicant |
| US8509867(B2) | 2013-08-01 | Workman et al. | Applicant |
| US8515509(B2) | 2013-08-01 | Bruinsma et al. | Applicant |
| US8523781(B2) | 2013-09-01 | Al-Ali | Applicant |
| US8529301(B2) | 2013-09-01 | Al-Ali et al. | Applicant |
| US8532727(B2) | 2013-09-01 | Ali et al. | Applicant |
| US8532728(B2) | 2013-09-01 | Diab et al. | Applicant |
| USD692145(S) | 2013-10-01 | Al-Ali et al. | Applicant |
| US8547209(B2) | 2013-10-01 | Kiani et al. | Examiner |
| US8548548(B2) | 2013-10-01 | Al-Ali | Applicant |
| US8548549(B2) | 2013-10-01 | Schurman et al. | Applicant |
| US8548550(B2) | 2013-10-01 | Al-Ali et al. | Applicant |
| US8554297(B2) | 2013-10-01 | Moon et al. | Applicant |
| US8560032(B2) | 2013-10-01 | Al-Ali et al. | Applicant |
| US8560034(B1) | 2013-10-01 | Diab et al. | Applicant |
| US8570167(B2) | 2013-10-01 | Al-Ali | Applicant |
| US8570503(B2) | 2013-10-01 | Vo et al. | Applicant |
| US8571617(B2) | 2013-10-01 | Reichgott et al. | Applicant |
| US8571618(B1) | 2013-10-01 | Lamego et al. | Applicant |
| US8571619(B2) | 2013-10-01 | Al-Ali et al. | Applicant |
| US8577431(B2) | 2013-11-01 | Lamego et al. | Applicant |
| US8581732(B2) | 2013-11-01 | Al-Ali et al. | Applicant |
| US8584345(B2) | 2013-11-01 | Al-Ali et al. | Applicant |
| US8588880(B2) | 2013-11-01 | Abdul-Hafiz et al. | Applicant |
| US8600467(B2) | 2013-12-01 | Al-Ali et al. | Applicant |
| US8606342(B2) | 2013-12-01 | Diab | Applicant |
| US8626255(B2) | 2014-01-01 | Al-Ali et al. | Applicant |
| US8630691(B2) | 2014-01-01 | Lamego et al. | Applicant |
| US8634889(B2) | 2014-01-01 | Al-Ali et al. | Applicant |
| US8641631(B2) | 2014-02-01 | Sierra et al. | Applicant |
| US8652060(B2) | 2014-02-01 | Al-Ali | Applicant |
| US8663107(B2) | 2014-03-01 | Kiani | Applicant |
| US8666468(B1) | 2014-03-01 | Al-Ali | Applicant |
| US8667967(B2) | 2014-03-01 | Al-Ali et al. | Applicant |
| US8670811(B2) | 2014-03-01 | O'Reilly | Applicant |
| US8670814(B2) | 2014-03-01 | Diab et al. | Applicant |
| US8676286(B2) | 2014-03-01 | Weber et al. | Applicant |
| US8682407(B2) | 2014-03-01 | Al-Ali | Applicant |
| USRE44823(E) | 2014-04-01 | Parker | Applicant |
| USRE44875(E) | 2014-04-01 | Kiani et al. | Applicant |
| US8690799(B2) | 2014-04-01 | Telfort et al. | Applicant |
| US8700112(B2) | 2014-04-01 | Kiani | Applicant |
| US8702627(B2) | 2014-04-01 | Telfort et al. | Applicant |
| US8706179(B2) | 2014-04-01 | Parker | Applicant |
| US8712494(B1) | 2014-04-01 | MacNeish, III et al. | Applicant |
| US8715206(B2) | 2014-05-01 | Telfort et al. | Applicant |
| US8718735(B2) | 2014-05-01 | Lamego et al. | Applicant |
| US8718737(B2) | 2014-05-01 | Diab et al. | Applicant |
| US8718738(B2) | 2014-05-01 | Blank et al. | Applicant |
| US8720249(B2) | 2014-05-01 | Al-Ali | Applicant |
| US8721541(B2) | 2014-05-01 | Al-Ali et al. | Applicant |
| US8721542(B2) | 2014-05-01 | Al-Ali et al. | Applicant |
| US8723677(B1) | 2014-05-01 | Kiani | Applicant |
| US8740792(B1) | 2014-06-01 | Kiani et al. | Applicant |
| US8754776(B2) | 2014-06-01 | Poeze et al. | Applicant |
| US8755535(B2) | 2014-06-01 | Telfort et al. | Applicant |
| US8755856(B2) | 2014-06-01 | Diab et al. | Applicant |
| US8755872(B1) | 2014-06-01 | Marinow | Applicant |
| US8761850(B2) | 2014-06-01 | Lamego | Applicant |
| US8764671(B2) | 2014-07-01 | Kiani | Applicant |
| US8768423(B2) | 2014-07-01 | Shakespeare et al. | Applicant |
| US8771204(B2) | 2014-07-01 | Telfort et al. | Applicant |
| US8777634(B2) | 2014-07-01 | Kiani et al. | Applicant |
| US8781543(B2) | 2014-07-01 | Diab et al. | Applicant |
| US8781544(B2) | 2014-07-01 | Al-Ali et al. | Applicant |
| US8781549(B2) | 2014-07-01 | Al-Ali et al. | Applicant |
| US8788003(B2) | 2014-07-01 | Schurman et al. | Applicant |
| US8790268(B2) | 2014-07-01 | Al-Ali | Applicant |
| US8801613(B2) | 2014-08-01 | Al-Ali et al. | Applicant |
| US8821397(B2) | 2014-09-01 | Al-Ali et al. | Applicant |
| US8821415(B2) | 2014-09-01 | Al-Ali et al. | Applicant |
| US8830449(B1) | 2014-09-01 | Lamego et al. | Applicant |
| US8831700(B2) | 2014-09-01 | Schurman et al. | Applicant |
| US8838196(B2) | 2014-09-01 | Mannheimer | Applicant |
| US8840549(B2) | 2014-09-01 | Al-Ali et al. | Applicant |
| US8847740(B2) | 2014-09-01 | Kiani et al. | Examiner |
| US8849365(B2) | 2014-09-01 | Smith et al. | Applicant |
| US8852094(B2) | 2014-10-01 | Al-Ali et al. | Applicant |
| US8852115(B2) | 2014-10-01 | Muir | Applicant |
| US8852994(B2) | 2014-10-01 | Wojtczuk et al. | Applicant |
| US8868147(B2) | 2014-10-01 | Stippick et al. | Applicant |
| US8868150(B2) | 2014-10-01 | Al-Ali et al. | Applicant |
| US8870792(B2) | 2014-10-01 | Al-Ali et al. | Applicant |
| US8886271(B2) | 2014-11-01 | Kiani et al. | Applicant |
| US8888539(B2) | 2014-11-01 | Al-Ali et al. | Applicant |
| US8888708(B2) | 2014-11-01 | Diab et al. | Applicant |
| US8892180(B2) | 2014-11-01 | Weber et al. | Applicant |
| US8897847(B2) | 2014-11-01 | Al-Ali | Applicant |
| US8909310(B2) | 2014-12-01 | Lamego et al. | Applicant |
| US8911377(B2) | 2014-12-01 | Al-Ali | Applicant |
| US8912909(B2) | 2014-12-01 | Al-Ali et al. | Applicant |
| US8920317(B2) | 2014-12-01 | Al-Ali et al. | Applicant |
| US8921699(B2) | 2014-12-01 | Al-Ali et al. | Applicant |
| US8922382(B2) | 2014-12-01 | Al-Ali et al. | Applicant |
| US8929964(B2) | 2015-01-01 | Al-Ali et al. | Applicant |
| US8942777(B2) | 2015-01-01 | Diab et al. | Applicant |
| US8948834(B2) | 2015-02-01 | Diab et al. | Applicant |
| US8948835(B2) | 2015-02-01 | Diab | Applicant |
| US8956294(B2) | 2015-02-01 | McCombie et al. | Applicant |
| US8965471(B2) | 2015-02-01 | Lamego | Applicant |
| US8983564(B2) | 2015-03-01 | Al-Ali | Applicant |
| US8989831(B2) | 2015-03-01 | Al-Ali et al. | Applicant |
| US8996085(B2) | 2015-03-01 | Kiani et al. | Applicant |
| US8998809(B2) | 2015-04-01 | Kiani | Applicant |
| US9028407(B1) | 2015-05-01 | Bennett-Guerrero | Examiner |
| US9028429(B2) | 2015-05-01 | Telfort et al. | Applicant |
| US9037207(B2) | 2015-05-01 | Al-Ali et al. | Applicant |
| US9060721(B2) | 2015-06-01 | Reichgott et al. | Applicant |
| US9066666(B2) | 2015-06-01 | Kiani | Applicant |
| US9066680(B1) | 2015-06-01 | Al-Ali et al. | Applicant |
| US9072474(B2) | 2015-07-01 | Al-Ali et al. | Applicant |
| US9078560(B2) | 2015-07-01 | Schurman et al. | Applicant |
| US9084569(B2) | 2015-07-01 | Weber et al. | Applicant |
| US9095316(B2) | 2015-08-01 | Welch et al. | Applicant |
| US9106038(B2) | 2015-08-01 | Telfort et al. | Applicant |
| US9107625(B2) | 2015-08-01 | Telfort et al. | Applicant |
| US9107626(B2) | 2015-08-01 | Al-Ali et al. | Applicant |
| US9113831(B2) | 2015-08-01 | Al-Ali | Applicant |
| US9113832(B2) | 2015-08-01 | Al-Ali | Applicant |
| US9119595(B2) | 2015-09-01 | Lamego | Applicant |
| US9131881(B2) | 2015-09-01 | Diab et al. | Applicant |
| US9131882(B2) | 2015-09-01 | Al-Ali et al. | Applicant |
| US9131883(B2) | 2015-09-01 | Al-Ali | Applicant |
| US9131917(B2) | 2015-09-01 | Telfort et al. | Applicant |
| US9138180(B1) | 2015-09-01 | Coverston et al. | Applicant |
| US9138182(B2) | 2015-09-01 | Al-Ali et al. | Applicant |
| US9138192(B2) | 2015-09-01 | Weber et al. | Applicant |
| US9142117(B2) | 2015-09-01 | Muhsin et al. | Applicant |
| US9153112(B1) | 2015-10-01 | Kiani et al. | Applicant |
| US9153121(B2) | 2015-10-01 | Kiani et al. | Applicant |
| US9161696(B2) | 2015-10-01 | Al-Ali et al. | Applicant |
| US9161713(B2) | 2015-10-01 | Al-Ali et al. | Applicant |
| US9167995(B2) | 2015-10-01 | Lamego et al. | Applicant |
| US9176141(B2) | 2015-11-01 | Al-Ali et al. | Applicant |
| US9186102(B2) | 2015-11-01 | Bruinsma et al. | Applicant |
| US9192312(B2) | 2015-11-01 | Al-Ali | Applicant |
| US9192329(B2) | 2015-11-01 | Al-Ali | Applicant |
| US9192351(B1) | 2015-11-01 | Telfort et al. | Applicant |
| US9195385(B2) | 2015-11-01 | Al-Ali et al. | Applicant |
| US9211072(B2) | 2015-12-01 | Kiani | Applicant |
| US9211095(B1) | 2015-12-01 | Al-Ali | Applicant |
| US9218454(B2) | 2015-12-01 | Kiani et al. | Applicant |
| US9226696(B2) | 2016-01-01 | Kiani | Applicant |
| US9241662(B2) | 2016-01-01 | Al-Ali et al. | Applicant |
| US9245668(B1) | 2016-01-01 | Vo et al. | Applicant |
| US9259185(B2) | 2016-02-01 | Abdul-Hafiz et al. | Applicant |
| US9267572(B2) | 2016-02-01 | Barker et al. | Applicant |
| US9277880(B2) | 2016-03-01 | Poeze et al. | Applicant |
| US9289167(B2) | 2016-03-01 | Diab et al. | Applicant |
| US9295421(B2) | 2016-03-01 | Kiani et al. | Applicant |
| US9307928(B1) | 2016-04-01 | Al-Ali et al. | Applicant |
| US9323894(B2) | 2016-04-01 | Kiani | Applicant |
| USD755392(S) | 2016-05-01 | Hwang et al. | Applicant |
| US9326712(B1) | 2016-05-01 | Kiani | Applicant |
| US9333316(B2) | 2016-05-01 | Kiani | Applicant |
| US9339220(B2) | 2016-05-01 | Lamego et al. | Applicant |
| US9341565(B2) | 2016-05-01 | Lamego et al. | Applicant |
| US9351673(B2) | 2016-05-01 | Diab et al. | Applicant |
| US9351675(B2) | 2016-05-01 | Al-Ali et al. | Applicant |
| US9364181(B2) | 2016-06-01 | Kiani et al. | Applicant |
| US9368671(B2) | 2016-06-01 | Wojtczuk et al. | Applicant |
| US9370325(B2) | 2016-06-01 | Al-Ali et al. | Applicant |
| US9370326(B2) | 2016-06-01 | McHale et al. | Applicant |
| US9370335(B2) | 2016-06-01 | Al-ali et al. | Applicant |
| US9375185(B2) | 2016-06-01 | Ali et al. | Applicant |
| US9386953(B2) | 2016-07-01 | Al-Ali | Applicant |
| US9386961(B2) | 2016-07-01 | Al-Ali et al. | Applicant |
| US9392945(B2) | 2016-07-01 | Al-Ali et al. | Applicant |
| US9397448(B2) | 2016-07-01 | Al-Ali et al. | Applicant |
| US9408542(B1) | 2016-08-01 | Kinast et al. | Applicant |
| US9436645(B2) | 2016-09-01 | Al-Ali et al. | Applicant |
| US9445759(B1) | 2016-09-01 | Lamego et al. | Applicant |
| US9466919(B2) | 2016-10-01 | Kiani et al. | Applicant |
| US9474474(B2) | 2016-10-01 | Lamego et al. | Applicant |
| US9480422(B2) | 2016-11-01 | Al-Ali | Applicant |
| US9480435(B2) | 2016-11-01 | Olsen | Applicant |
| US9492110(B2) | 2016-11-01 | Al-Ali et al. | Applicant |
| US9510779(B2) | 2016-12-01 | Poeze et al. | Applicant |
| US9517024(B2) | 2016-12-01 | Kiani et al. | Applicant |
| US9532722(B2) | 2017-01-01 | Lamego et al. | Applicant |
| US9538949(B2) | 2017-01-01 | Al-Ali et al. | Applicant |
| US9538980(B2) | 2017-01-01 | Telfort et al. | Applicant |
| US9549696(B2) | 2017-01-01 | Lamego et al. | Applicant |
| US9554737(B2) | 2017-01-01 | Schurman et al. | Applicant |
| US9560996(B2) | 2017-02-01 | Kiani | Applicant |
| US9560998(B2) | 2017-02-01 | Al-Ali et al. | Applicant |
| US9566019(B2) | 2017-02-01 | Al-Ali et al. | Applicant |
| US9579039(B2) | 2017-02-01 | Jansen et al. | Applicant |
| US9591975(B2) | 2017-03-01 | Dalvi et al. | Applicant |
| US9622693(B2) | 2017-04-01 | Diab | Applicant |
| US2002/0161291(A1) | 2002-10-01 | Kianl et al. | Applicant |
| US2003/0137423(A1) | 2003-07-01 | Al-Ali | Applicant |
| US2003/0191358(A1) | 2003-10-01 | MacKin et al. | Applicant |
| US2004/0162499(A1) | 2004-08-01 | Nagai et al. | Applicant |
| US2005/0027182(A1) | 2005-02-01 | Siddiqui | Examiner |
| US2005/0177096(A1) | 2005-08-01 | Bollish | Examiner |
| US2005/0240091(A1) | 2005-10-01 | Lynn | Applicant |
| US2006/0220881(A1) | 2006-10-01 | Al-Ali | Examiner |
| US2007/0040692(A1) | 2007-02-01 | Smith et al. | Examiner |
| US2007/0282478(A1) | 2007-12-01 | Al-Ali et al. | Applicant |
| US2008/0103375(A1) | 2008-05-01 | Kiani | Applicant |
| US2008/0244425(A1) | 2008-10-01 | Kikin-Gil et al. | Applicant |
| US2008/0255438(A1) | 2008-10-01 | Saidara | Examiner |
| US2008/0281168(A1) | 2008-11-01 | Gibson | Examiner |
| US2009/0040874(A1) | 2009-02-01 | Rooney | Examiner |
| US2009/0247848(A1) | 2009-10-01 | Baker | Applicant |
| US2009/0247849(A1) | 2009-10-01 | McCutcheon et al. | Applicant |
| US2009/0247984(A1) | 2009-10-01 | Lamego et al. | Applicant |
| US2009/0275813(A1) | 2009-11-01 | Davis | Applicant |
| US2009/0275844(A1) | 2009-11-01 | Al-Ali | Applicant |
| US2010/0004518(A1) | 2010-01-01 | Vo et al. | Applicant |
| US2010/0030040(A1) | 2010-02-01 | Poeze et al. | Applicant |
| US2010/0113904(A1) | 2010-05-01 | Batchelder et al. | Applicant |
| US2010/0331656(A1) | 2010-12-01 | Mensinger et al. | Applicant |
| US2011/0082711(A1) | 2011-04-01 | Poeze et al. | Applicant |
| US2011/0105854(A1) | 2011-05-01 | Kiani et al. | Applicant |
| US2011/0125060(A1) | 2011-05-01 | Telfort et al. | Applicant |
| US2011/0208015(A1) | 2011-08-01 | Welch et al. | Applicant |
| US2011/0213212(A1) | 2011-09-01 | Al-Ali | Applicant |
| US2011/0230733(A1) | 2011-09-01 | Al-Ali | Applicant |
| US2011/0237969(A1) | 2011-09-01 | Eckerbom et al. | Applicant |
| US2011/0288383(A1) | 2011-11-01 | Diab | Applicant |
| US2012/0041316(A1) | 2012-02-01 | Al-Ali et al. | Applicant |
| US2012/0046557(A1) | 2012-02-01 | Kiani | Applicant |
| US2012/0059267(A1) | 2012-03-01 | Lamego et al. | Applicant |
| US2012/0088984(A1) | 2012-04-01 | Al-Ali et al. | Applicant |
| US2012/0105233(A1) | 2012-05-01 | Bobey et al. | Applicant |
| US2012/0165629(A1) | 2012-06-01 | Merritt et al. | Applicant |
| US2012/0209082(A1) | 2012-08-01 | Al-Ali | Applicant |
| US2012/0209084(A1) | 2012-08-01 | Olsen et al. | Applicant |
| US2012/0232366(A1) | 2012-09-01 | Kiani | Examiner |
| US2012/0283524(A1) | 2012-11-01 | Kiani et al. | Applicant |
| US2012/0296178(A1) | 2012-11-01 | Lamego et al. | Applicant |
| US2012/0303085(A1) | 2012-11-01 | Vitense et al. | Applicant |
| US2012/0319816(A1) | 2012-12-01 | Al-Ali | Applicant |
| US2013/0023775(A1) | 2013-01-01 | Lamego et al. | Applicant |
| US2013/0041591(A1) | 2013-02-01 | Lamego | Applicant |
| US2013/0046204(A1) | 2013-02-01 | Lamego et al. | Applicant |
| US2013/0060147(A1) | 2013-03-01 | Welch et al. | Applicant |
| US2013/0096405(A1) | 2013-04-01 | Garfio | Applicant |
| US2013/0096936(A1) | 2013-04-01 | Sampath et al. | Applicant |
| US2013/0243021(A1) | 2013-09-01 | Siskavich | Applicant |
| US2013/0253334(A1) | 2013-09-01 | Al-Ali et al. | Applicant |
| US2013/0267804(A1) | 2013-10-01 | Al-Ali | Applicant |
| US2013/0274572(A1) | 2013-10-01 | Al-Ali et al. | Applicant |
| US2013/0296672(A1) | 2013-11-01 | O'Neil et al. | Applicant |
| US2013/0296713(A1) | 2013-11-01 | Al-Ali et al. | Applicant |
| US2013/0324808(A1) | 2013-12-01 | Al-Ali et al. | Applicant |
| US2013/0331660(A1) | 2013-12-01 | Al-Ali et al. | Applicant |
| US2013/0331670(A1) | 2013-12-01 | Kiani | Applicant |
| US2014/0012100(A1) | 2014-01-01 | Al-Ali et al. | Applicant |
| US2014/0034353(A1) | 2014-02-01 | Al-Ali et al. | Applicant |
| US2014/0051953(A1) | 2014-02-01 | Lamego et al. | Applicant |
| US2014/0066783(A1) | 2014-03-01 | Kiani et al. | Applicant |
| US2014/0077956(A1) | 2014-03-01 | Sampath et al. | Applicant |
| US2014/0081100(A1) | 2014-03-01 | Muhsin et al. | Applicant |
| US2014/0081175(A1) | 2014-03-01 | Telfort | Applicant |
| US2014/0100434(A1) | 2014-04-01 | Diab et al. | Applicant |
| US2014/0114199(A1) | 2014-04-01 | Lamego et al. | Applicant |
| US2014/0120564(A1) | 2014-05-01 | Workman et al. | Applicant |
| US2014/0121482(A1) | 2014-05-01 | Merritt et al. | Applicant |
| US2014/0127137(A1) | 2014-05-01 | Bellott et al. | Applicant |
| US2014/0129702(A1) | 2014-05-01 | Lamego et al. | Applicant |
| US2014/0135588(A1) | 2014-05-01 | Al-Ali et al. | Applicant |
| US2014/0142401(A1) | 2014-05-01 | Al-Ali et al. | Applicant |
| US2014/0163344(A1) | 2014-06-01 | Al-Ali | Applicant |
| US2014/0163402(A1) | 2014-06-01 | Lamego et al. | Applicant |
| US2014/0166076(A1) | 2014-06-01 | Kiani et al. | Applicant |
| US2014/0171763(A1) | 2014-06-01 | Diab | Applicant |
| US2014/0180038(A1) | 2014-06-01 | Kiani | Applicant |
| US2014/0180154(A1) | 2014-06-01 | Sierra et al. | Applicant |
| US2014/0180160(A1) | 2014-06-01 | Brown et al. | Applicant |
| US2014/0187973(A1) | 2014-07-01 | Brown et al. | Applicant |
| US2014/0213864(A1) | 2014-07-01 | Abdul-Hafiz et al. | Applicant |
| US2014/0266790(A1) | 2014-09-01 | Al-Ali et al. | Applicant |
| US2014/0275808(A1) | 2014-09-01 | Poeze et al. | Applicant |
| US2014/0275835(A1) | 2014-09-01 | Lamego et al. | Applicant |
| US2014/0275871(A1) | 2014-09-01 | Lamego et al. | Applicant |
| US2014/0275872(A1) | 2014-09-01 | Merritt et al. | Applicant |
| US2014/0276115(A1) | 2014-09-01 | Dalvi et al. | Applicant |
| US2014/0288400(A1) | 2014-09-01 | Diab et al. | Applicant |
| US2014/0309507(A1) | 2014-10-01 | Baker, Jr. | Applicant |
| US2014/0316217(A1) | 2014-10-01 | Purdon et al. | Applicant |
| US2014/0316218(A1) | 2014-10-01 | Purdon et al. | Applicant |
| US2014/0316228(A1) | 2014-10-01 | Blank et al. | Applicant |
| US2014/0323825(A1) | 2014-10-01 | Al-Ali et al. | Applicant |
| US2014/0323897(A1) | 2014-10-01 | Brown et al. | Applicant |
| US2014/0323898(A1) | 2014-10-01 | Purdon et al. | Applicant |
| US2014/0330092(A1) | 2014-11-01 | Al-Ali et al. | Applicant |
| US2014/0330098(A1) | 2014-11-01 | Merritt et al. | Applicant |
| US2014/0330099(A1) | 2014-11-01 | Al-Ali et al. | Applicant |
| US2014/0336481(A1) | 2014-11-01 | Shakespeare et al. | Applicant |
| US2014/0357966(A1) | 2014-12-01 | Al-Ali et al. | Applicant |
| US2015/0005600(A1) | 2015-01-01 | Blank et al. | Applicant |
| US2015/0011907(A1) | 2015-01-01 | Purdon et al. | Applicant |
| US2015/0012231(A1) | 2015-01-01 | Poeze et al. | Applicant |
| US2015/0025406(A1) | 2015-01-01 | Al-Ali | Applicant |
| US2015/0032029(A1) | 2015-01-01 | Al-Ali et al. | Applicant |
| US2015/0038859(A1) | 2015-02-01 | Dalvi et al. | Applicant |
| US2015/0045637(A1) | 2015-02-01 | Dalvi | Applicant |
| US2015/0051462(A1) | 2015-02-01 | Olsen | Applicant |
| US2015/0080754(A1) | 2015-03-01 | Purdon et al. | Applicant |
| US2015/0087936(A1) | 2015-03-01 | Al-Ali et al. | Applicant |
| US2015/0094546(A1) | 2015-04-01 | Al-Ali | Applicant |
| US2015/0097701(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0099950(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0099951(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0099955(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0101844(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0106121(A1) | 2015-04-01 | Muhsin et al. | Applicant |
| US2015/0112151(A1) | 2015-04-01 | Muhsin et al. | Applicant |
| US2015/0116076(A1) | 2015-04-01 | Al-Ali et al. | Applicant |
| US2015/0126830(A1) | 2015-05-01 | Schurman et al. | Applicant |
| US2015/0133755(A1) | 2015-05-01 | Smith et al. | Applicant |
| US2015/0141781(A1) | 2015-05-01 | Weber et al. | Applicant |
| US2015/0165312(A1) | 2015-06-01 | Kiani | Applicant |
| US2015/0196237(A1) | 2015-07-01 | Lamego | Applicant |
| US2015/0216459(A1) | 2015-08-01 | Al-Ali et al. | Applicant |
| US2015/0230755(A1) | 2015-08-01 | Al-Ali et al. | Applicant |
| US2015/0233722(A1) | 2015-08-01 | Al-Ali | Applicant |
| US2015/0245773(A1) | 2015-09-01 | Lamego et al. | Applicant |
| US2015/0245794(A1) | 2015-09-01 | Al-Ali | Applicant |
| US2015/0257689(A1) | 2015-09-01 | Al-Ali et al. | Applicant |
| US2015/0272514(A1) | 2015-10-01 | Kiani et al. | Applicant |
| US2015/0351697(A1) | 2015-12-01 | Weber et al. | Applicant |
| US2015/0351704(A1) | 2015-12-01 | Kiani et al. | Applicant |
| US2015/0359429(A1) | 2015-12-01 | Al-Ali et al. | Applicant |
| US2015/0366472(A1) | 2015-12-01 | Kiani | Applicant |
| US2015/0366507(A1) | 2015-12-01 | Blank | Applicant |
| US2015/0374298(A1) | 2015-12-01 | Al-Ali et al. | Applicant |
| US2015/0380875(A1) | 2015-12-01 | Coverston et al. | Applicant |
| US2016/0000362(A1) | 2016-01-01 | Diab et al. | Applicant |
| US2016/0007930(A1) | 2016-01-01 | Weber et al. | Applicant |
| US2016/0029932(A1) | 2016-02-01 | Al-Ali | Applicant |
| US2016/0045118(A1) | 2016-02-01 | Kiani | Applicant |
| US2016/0051205(A1) | 2016-02-01 | Al-Ali et al. | Applicant |
| US2016/0058338(A1) | 2016-03-01 | Schurman et al. | Applicant |
| US2016/0058347(A1) | 2016-03-01 | Reichgott et al. | Applicant |
| US2016/0066823(A1) | 2016-03-01 | Kind et al. | Applicant |
| US2016/0066824(A1) | 2016-03-01 | Al-Ali et al. | Applicant |
| US2016/0066879(A1) | 2016-03-01 | Telfort et al. | Applicant |
| US2016/0072429(A1) | 2016-03-01 | Kiani et al. | Applicant |
| US2016/0081552(A1) | 2016-03-01 | Wojtczuk et al. | Applicant |
| US2016/0095543(A1) | 2016-04-01 | Telfort et al. | Applicant |
| US2016/0095548(A1) | 2016-04-01 | Al-Ali et al. | Applicant |
| US2016/0103598(A1) | 2016-04-01 | Al-Ali et al. | Applicant |
| US2016/0113527(A1) | 2016-04-01 | Al-Ali | Applicant |
| US2016/0143548(A1) | 2016-05-01 | Al-Ali | Applicant |
| US2016/0166182(A1) | 2016-06-01 | Al-Ali et al. | Applicant |
| US2016/0166183(A1) | 2016-06-01 | Poeze et al. | Applicant |
| US2016/0166188(A1) | 2016-06-01 | Bruinsma et al. | Applicant |
| US2016/0166210(A1) | 2016-06-01 | Al-Ali | Applicant |
| US2016/0192869(A1) | 2016-07-01 | Kiani et al. | Applicant |
| US2016/0196388(A1) | 2016-07-01 | Lamego | Applicant |
| US2016/0197436(A1) | 2016-07-01 | Barker et al. | Applicant |
| US2016/0213281(A1) | 2016-07-01 | Eckerbom et al. | Applicant |
| US2016/0228043(A1) | 2016-08-01 | O'Neil et al. | Applicant |
| US2016/0233632(A1) | 2016-08-01 | Scruggs et al. | Applicant |
| US2016/0234944(A1) | 2016-08-01 | Schmidt et al. | Applicant |
| US2016/0270735(A1) | 2016-09-01 | Diab et al. | Applicant |
| US2016/0283665(A1) | 2016-09-01 | Sampath et al. | Applicant |
| US2016/0287090(A1) | 2016-10-01 | Al-Ali et al. | Applicant |
| US2016/0287786(A1) | 2016-10-01 | Kiani | Applicant |
| US2016/0296169(A1) | 2016-10-01 | McHale et al. | Applicant |
| US2016/0310052(A1) | 2016-10-01 | Al-Ali et al. | Applicant |
| US2016/0314260(A1) | 2016-10-01 | Kiani | Applicant |
| US2016/0324486(A1) | 2016-11-01 | Al-Ali et al. | Applicant |
| US2016/0324488(A1) | 2016-11-01 | Olsen | Applicant |
| US2016/0327984(A1) | 2016-11-01 | Al-Ali et al. | Applicant |
| US2016/0328528(A1) | 2016-11-01 | Al-Ali et al. | Applicant |
| US2016/0331332(A1) | 2016-11-01 | Al-Ali | Applicant |
| US2016/0367173(A1) | 2016-12-01 | Dalvi et al. | Applicant |
| US2017/0007134(A1) | 2017-01-01 | Al-Ali et al. | Applicant |
| US2017/0007190(A1) | 2017-01-01 | Al-Ali et al. | Applicant |
| US2017/0007198(A1) | 2017-01-01 | Al-Ali et al. | Applicant |
| US2017/0014084(A1) | 2017-01-01 | Al-Ali et al. | Applicant |
| US2017/0021099(A1) | 2017-01-01 | Al-Ali et al. | Applicant |
| US2017/0027456(A1) | 2017-02-01 | Kinast et al. | Applicant |
| US2017/0042488(A1) | 2017-02-01 | Muhsin | Applicant |
| US2017/0055847(A1) | 2017-03-01 | Kiani et al. | Applicant |
| US2017/0055851(A1) | 2017-03-01 | Al-Ali | Applicant |
| US2017/0055882(A1) | 2017-03-01 | Al-Ali et al. | Applicant |
| US2017/0055887(A1) | 2017-03-01 | Al-Ali | Applicant |
| US2017/0055896(A1) | 2017-03-01 | Al-Ali et al. | Applicant |
| US2017/0079594(A1) | 2017-03-01 | Telfort et al. | Applicant |
| US2017/0086723(A1) | 2017-03-01 | Al-Ali et al. | Applicant |
| WO2005/087097 | 2005-09-01 | Applicant | |
| WO2010/014743 | 2010-02-01 | Applicant |
Non-Patent Literature (29)
- US 9,579,050, 02/2017, Al-Ali (withdrawn)Applicant
- Rheineck-Leyssius, MD, et al., “Advanced Pulse Oximeter Signal Processing Technology Compared to Simple Averaging. I. Effect on Frequency of Alarms in the Operating Room”, Journal of Clinical Anesthesia, The Netherlands, May 1999, vol. 11, pp. 192-195.Applicant
- Cust, AE, et al., “Alarm settings for the Marquette 8000 pulse oximeter to prevent hyperoxic and hypoxic episodes”, Journal Paediatric Child Health, 1999, vol. 35, pp. 159-162.Applicant
- Lawless, Stephen T., “Crying wolf: False alarms in a pediatric intensive care unit”, Critical Care Medicine, 1994, vol. 22, No. 6, pp. 981-985.Applicant
- Informal Expert Report of Dr. Stephen Barker, Lead Case No. 16-05968-LT11, executed Feb. 10, 2017.Applicant
- Impact of Clinical Alarms on Patient Safety, ACCE Healthcare Technology Foundation, 2006, 20 pages.Applicant
- Taenzer, M.D., Andreas, “Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers”, The American Society of Anesthesiologists, Inc., Feb. 2010, vol. 112, No. 2, pp. 282-287.Applicant
- Stefanescu, MD MSc, Beatrice, “Improved Filtering of Pulse Oximeter Monitoring Alarms in the Neonatal ICU: Bedside Significance”, Respiratory Care, Jan. 2016, vol. 61, No. 1, pp. 85-89.Applicant
- Rheineck-Leyssius, A.T., et al., “Influence of pulse oximeter lower alarm limit on the incidence of hypoxaemia in the recovery room”, British Journal of Anaesthesia, 1997, vol. 79, pp. 460-464.Applicant
- Rheineck-Leyssius, MD, Aart, et al., “Influence of Pulse Oximeter Settings on the Frequency of Alarms, and Detection of Hypoxemia”, Journal of Clinical Monitoring and Computing, 1998, vol. 14, pp. 151-156.Applicant
- Pan, MD., Peter, “Intraoperative Pulse Oximetry: Frequency and Distribution of Discrepant Data”, Journal of Clinical Monitoring and Computing, Nov./Dec. 1994, vol. 6, pp. 491-495.Applicant
- Graham, Kelly, et al., Monitor Alarm Fatigue: Standardizing Use of Physiological Monitors and Decreasing Nuisance Alarms, American Journal of Critical Care, Jan. 2010, vol. 19, No. 1, pp. 27-37.Applicant
- Barker, PhD, MD, Steven, “‘Motion-Resistant’ Pulse Oximetry: A Comparison of New and Old Models” Department of Anesthesiology, 2002, vol. 95, pp. 967-972.Applicant
- National Patient Safety Goals Effective Jan. 1, 2015, Hospital Accreditation Program, The Joint Commission, Jan. 2015, pp. 1-17.Applicant
- Brostowicz, Heather, et al. Oxygen saturation monitoring in the Neonatal Intensive Care Unit (NICU): Evaluation of a new alarm management, Journal of Neonatal-Perinatal Medicine 3, 2010, pp. 135-139.Applicant
- Kowalczyk, Liz, “Patient alarms often unheard, unheeded” The Boston Globe, Feb. 13, 2011, in 5 pages.Applicant
- Taenzer, Andreas, et al., “Postoperative Monitoring—The Dartmouth Experience”, The Official Journal of the Anesthesia Patient Safety Foundation, Spring-Summer 2012, vol. 27, No. 1, pp. 1-28.Applicant
- Tobin, Martin, “Principles and Practice of Intensive Care Monitoring”, 1998, in 30 pages.Applicant
- Severinghaus, M.D., John, et al., Pulse Oximeter Failure Thresholds in Hypotension and Vasoconstriction, Anesthesiology, Sep. 1990, vol. 73, No. 3, pp. 532-537.Applicant
- Pologe, Jonas A., “Pulse Oximetry: Technical Aspects of Machine Design”, International Anesthesiology Clinics, Advances in Oxygen Monitoring, Fall, 1987, vol. 25, No. 3, pp. 137-153.Applicant
- Tremper, Ph.D., Kevin et al., “Pulse Oximetry”, Medical Intelligence Article, Anesthesiology, Jan. 1989, vol. 70, No. 1, pp. 98-108.Applicant
- Bosque, PhD, Elena, “Symbiosis of nurse and machine through fuzzy logic: Improved specificity of a neonatal pulse oximeter alarm”, Dec. 1995, vol. 18, Issue 2, pp. 67-75.Applicant
- Paine, MPH, Christine, et al., “Systematic review of physiologic monitor alarm characteristics and pragmatic interventions to reduce alarm frequency” J Hosp Med., Feb. 2017, vol. 11, No. 2, pp. 136-144.Applicant
- Top 10 Technology Hazards for 2012, Guidance Article, Nov. 2011, www.ecri.org, pp. 358-373.Applicant
- Top 10 Technology Hazards for 2013, Health Devices, ECRI Institute, Nov. 2012, reprinted from vol. 41, Issue 11, in 25 pages.Applicant
- Top 10 Health Technology Hazards for 2014, Health Devices, ECRI Institute, Nov. 2013, www.ecri.org/2014hazards, 1 page.Applicant
- Masimo Advanced Alarm Performance: An Evidence-Based Approach to Reduce False Alarms and Nuisance Alarms, 2010, in 8 pages.Applicant
- International Search Report for PCT/US2009/052146, dated Dec. 15, 2009.Applicant
- International Preliminary Report on Patentability and Written Opinion for PCT/US2009/052146 dated Feb. 10, 2011.Applicant